Skip to main content

CRMP4 Antibody (1B8)

Novus Biologicals, part of Bio-Techne | Catalog # H00001809-M01

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
H00001809-M01

Key Product Details

Species Reactivity

Human

Applications

ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Sandwich ELISA, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG2a Kappa Clone # 1B8

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

DPYSL3 (NP_001378, 457 a.a. ~ 555 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. GNLHVTQGAGRFIPCSPFSDYVYKRIKARRKMADLHAVPRGMYDGPVFDLTTTPKGGTPAGSARGSPTRPNPPVRNLHQSGFSLSGTQVDEGVRSASKR

Specificity

DPYSL3 - dihydropyrimidinase-like 3

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2a Kappa

Description

Quality control test: Antibody Reactive Against Recombinant Protein.

Scientific Data Images for CRMP4 Antibody (1B8)

Western Blot: CRMP4 Antibody (1B8) [H00001809-M01]

Western Blot: CRMP4 Antibody (1B8) [H00001809-M01]

Western Blot: CRMP4 Antibody (1B8) [H00001809-M01] - DPYSL3 monoclonal antibody (M01), clone 1B8 Analysis of DPYSL3 expression in Jurkat.
Immunohistochemistry-Paraffin: CRMP4 Antibody (1B8) [H00001809-M01]

Immunohistochemistry-Paraffin: CRMP4 Antibody (1B8) [H00001809-M01]

Immunohistochemistry-Paraffin: CRMP4 Antibody (1B8) [H00001809-M01] - Analysis of monoclonal antibody to DPYSL3 on formalin-fixed paraffin-embedded human ovary. Antibody concentration 3 ug/ml.
Sandwich ELISA: CRMP4 Antibody (1B8) [H00001809-M01] - Detection limit for recombinant GST tagged DPYSL3 is 0.3 ng/ml as a capture antibody.

Applications for CRMP4 Antibody (1B8)

Application
Recommended Usage

Immunohistochemistry

1:10-1:500

Immunohistochemistry-Paraffin

1:10-1:500

Sandwich ELISA

1:100-1:2000

Western Blot

1:500
Application Notes
Antibody reactivity against cell lysate and recombinant protein for WB. It has also been used for ELISA and IHC-P.

Formulation, Preparation, and Storage

Purification

IgG purified

Formulation

In 1x PBS, pH 7.4

Preservative

No Preservative

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.

Background: CRMP4

The collapsin response mediator protein (CRMP) family of five cytosolic phosphoproteins are highly expressed throughout brain development. The functions of CRMPs encompass signal transduction in developmental guidance cues as well as multiple cellular and molecular events involved in apoptosis/proliferation, cell migration, and differentiation. In the adult brain, the expression of CRMPs is dramatically downregulated. However, CRMPs remain expressed in structures that retain their capacity for differentiation and plasticity. The expression of CRMPs is altered in neurodegenerative diseases, and these proteins may have a role in the physiopathology of the adult nervous system.

Alternate Names

Collapsin response mediator protein 4, CRMP-4, CRMP4collapsin response mediator protein 4 long, dihydropyrimidinase-like 3, DRP-3dihydropyrimidinase-related protein 3, DRP3ULIP1, ULIP-1, ULIPLCRMP, Unc-33-like phosphoprotein 1

Entrez Gene IDs

1809 (Human)

Gene Symbol

DPYSL3

OMIM

601168 (Human)

Additional CRMP4 Products

Product Documents for CRMP4 Antibody (1B8)

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CRMP4 Antibody (1B8)

This product is produced by and distributed for Abnova, a company based in Taiwan.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...